Home » Stocks » NMRD » Company

Nemaura Medical Inc. (NMRD)

Stock Price: $7.82 USD -0.07 (-0.89%)
Updated Jul 27, 2021 4:00 PM EDT - Market closed
Nemaura Medical Inc.
Country United States
Founded 2009
Industry Medical Devices
Sector Healthcare
Employees 25
CEO Dewan Chowdhury

Contact Details

Address:57 W 57th St
New York, New York 10019-2802
United States
Phone 646 416 8000

Stock Information

Ticker Symbol NMRD
Exchange NASDAQ
Fiscal Year April - March
Reporting Currency US Dollars
CIK Code 0001602078
CUSIP Number 640442109
ISIN Number US6404422080
Employer ID 46-5027260

Company Description

Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices.

It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients.

The company was founded in 2009 and is based in New York, New York.

Key Executives

NamePosition
Dr. Dewan Fazlul Hoque Chowdhury Ph.D.Chairman, Chief Executive Officer and Pres
Justin MclarneyChief Finance Officer
Jay L. WarnerHead of U.S. Commercial Operations
Thomas Bendix MortensenHead of E.U. Commercial Operations and Marketing
Samantha SandersGlobal Head of Digital Programs

Latest SEC Filings

DateTypeTitle
Jul 26, 20218-KCurrent report
Jul 23, 2021424B5Prospectus [Rule 424(b)(5)]
Jul 23, 20218-KCurrent report
Jul 13, 2021DEF 14AOther definitive proxy statements
Jun 30, 20218-KCurrent report
Jun 29, 202110-KAnnual report [Section 13 and 15(d), not S-K Item 405]
May 14, 20218-KCurrent report
May 5, 20218-KCurrent report
Apr 28, 20218-KCurrent report
Apr 13, 20218-KCurrent report
View All SEC filings